Visual analysis on ferroptosis and its cross-talk to coronavirus disease 2019 (COVID-19)

Junda Zhou1, Wenjia Ni2, Xianqin Zhang2

  • 1College of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, China.

Heliyon
|September 18, 2024
PubMed

Insights

Ferroptosis, a programmed cell death, is linked to COVID-19 through 13 shared genes, offering potential new therapeutic targets. This research visualizes ferroptosis studies and identifies key genes for future COVID-19 treatments.

Area of Science:

  • Biomedical Science
  • Cell Biology
  • Immunology

Background:

  • Ferroptosis is a distinct form of programmed cell death.
  • Despite extensive research, the role of ferroptosis in COVID-19 pathogenesis remains underexplored.
  • COVID-19 continues to be a global health concern, with ongoing research into its mechanisms crucial for pandemic mitigation.

Purpose of the Study:

  • To conduct a bibliometric and visual analysis of ferroptosis research.
  • To identify shared genes between ferroptosis and COVID-19.
  • To provide insights into potential therapeutic targets for COVID-19.

Main Methods:

  • Bibliometric and visual atlas analysis using CiteSpace 6.2 R4 software.
  • Gene mining for ferroptosis and COVID-19 using the Genecards database.
  • Identification of shared genes and pathway enrichment analysis.

Main Results:

  • A growing body of research on ferroptosis was observed, with significant contributions from China and the United States.
  • Thirteen genes were identified as shared between ferroptosis and COVID-19.
  • These shared genes, including TNF, RELA, and ATF4, are primarily enriched in tumor necrosis factor pathways and are upregulated during oxidative stress responses.

Conclusions:

  • The identified shared genes represent potential novel therapeutic targets for COVID-19.
  • Understanding the role of ferroptosis in SARS-CoV-2 infection is critical for developing effective treatment strategies.
  • This study provides a valuable reference for future research and clinical interventions related to ferroptosis and COVID-19.
Abstract